DEAD

Serial Number

78757030

Owner

SAVIENT PHARMACEUTICALS, INC.

Attorney

Howard R. Fine

Filing Date

Nov 18, 2005

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ROSEMONT Trademark

Serial Number: 78757030 • Registration: 3660957

ROSEMONT is a trademark filed by SAVIENT PHARMACEUTICALS, INC. on November 18, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

SAVIENT PHARMACEUTICALS, INC. (20 trademarks)

14TH FLOOR
EAST BRUNSWICK, NJ 08816

Entity Type: 03

ROSEMONT PHARMACEUTICALS LTD. (11 trademarks)

BRAITHWAITE STREET
LEEDS LS11 9XE , GB

Entity Type: 03

Legal Representation

Attorney of Record

Howard R. Fine

1,058 trademarks filed View all →

Trademark Details

Filing Date

November 18, 2005

Registration Date

July 28, 2009

Published for Opposition

May 12, 2009

Cancellation Date

March 4, 2016

Goods & Services

Liquid pharmaceuticals, namely, Antibacterial pharmaceuticals, Anti-diabetic pharmaceuticals, Cardiovascular pharmaceuticals, Lipid lowering agents, Psychotropics, and Anti-infectives; Liquid pharmaceutical preparations, namely, anticoagulants; Liquid pharmaceutical preparations, namely, antidepressants; Liquid pharmaceutical preparation for the treatment of gout; Liquid pharmaceutical preparations for the treatment of heart rhythm disorders; Liquid pharmaceutical preparations acting on the central nervous system; Liquid pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Liquid pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Liquid pharmaceutical preparations for treating diabetes; Liquid pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Liquid pharmaceutical preparations for the treatment of inflammatory disorders; Liquid pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Liquid pharmaceutical products for the treatment of bone diseases; Liquid pharmaceutical products for the treatment of viral and infectious diseases, and for the treatment of cancer

Filing History

CANCELLED SEC. 8 (6-YR)

Mar 4, 2016 C8..

REGISTERED-PRINCIPAL REGISTER

Jul 28, 2009 R.PR

PUBLISHED FOR OPPOSITION

May 12, 2009 PUBO

NOTICE OF PUBLICATION

Apr 22, 2009 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 4, 2009 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 1, 2009 CNSA

DATA MODIFICATION COMPLETED

Mar 30, 2009 DMCC

DATA MODIFICATION COMPLETED

Mar 23, 2009 DMCC

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Mar 18, 2009 ASCK

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2009 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 13, 2009 CRFA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2009 TEME

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 11, 2009 TROA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Feb 11, 2009 GPRN

PRIORITY ACTION E-MAILED

Feb 11, 2009 GPRA

PRIORITY ACTION WRITTEN

Feb 11, 2009 CPRA

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Feb 6, 2009 ZZZX

1(B) BASIS DELETED; NEW BASIS REQUESTED

Feb 3, 2009 ADBS

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

Jan 29, 2009 PCBG

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 26, 2009 AITU

ASSIGNED TO PETITION STAFF

Jan 23, 2009 APET

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 22, 2009 CRFA

NOTICE OF ALLOWANCE CANCELLED

Jan 22, 2009 IUCN

TEAS POST PUBLICATION AMENDMENT RECEIVED

Jan 22, 2009 EPPA

PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED

Jan 22, 2009 PDCB

FAX RECEIVED

Jan 22, 2009 FAXX

SOU EXTENSION 3 GRANTED

Oct 27, 2008 EX3G

SOU EXTENSION 3 FILED

Oct 27, 2008 EXT3

SOU TEAS EXTENSION RECEIVED

Oct 27, 2008 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 25, 2008 TCCA

SOU EXTENSION 2 GRANTED

May 7, 2008 EX2G

SOU EXTENSION 2 FILED

May 7, 2008 EXT2

SOU TEAS EXTENSION RECEIVED

May 7, 2008 EEXT

SOU EXTENSION 1 GRANTED

Nov 14, 2007 EX1G

SOU EXTENSION 1 FILED

Nov 14, 2007 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 14, 2007 EEXT

NOA MAILED - SOU REQUIRED FROM APPLICANT

May 15, 2007 NOAM

PUBLISHED FOR OPPOSITION

Feb 20, 2007 PUBO

NOTICE OF PUBLICATION

Jan 31, 2007 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 29, 2006 PREV

ASSIGNED TO LIE

Dec 29, 2006 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 11, 2006 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 29, 2006 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 28, 2006 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 28, 2006 TROA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 23, 2006 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 23, 2006 REAP

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Aug 23, 2006 ASGN

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jun 21, 2006 ASCK

NON-FINAL ACTION E-MAILED

May 30, 2006 GNRT

NON-FINAL ACTION WRITTEN

May 30, 2006 CNRT

ASSIGNED TO EXAMINER

May 24, 2006 DOCK

NOTICE OF DESIGN SEARCH CODE MAILED

Nov 26, 2005 MDSC

NEW APPLICATION ENTERED

Nov 25, 2005 NWAP

Related Trademarks

More from this Owner

ROSEMONT

R ROSEMONT

More in Same Class

PEOPLEPAX

PDL BIOPHARMA

GLORIAMIX

NUEWAY

MEGAHEALTH